Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.850
0.00 (0.00%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $207.07 million as of July 31, 2026. Its market cap has increased by 145.56% in one year.
Market Cap
207.07M
Enterprise Value
84.02M
1-Year Change
145.56%
Ranking
Category
Stock Price
$3.85
ChartMarket Cap Chart
Since August 27, 2021, Whitehawk Therapeutics's market cap has decreased from $540.80M to $207.07M, a decrease of -61.71%. That is a compound annual growth rate of -17.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 207.07M | 81.56% |
| Dec 31, 2025 | 114.05M | 46.67% |
| Dec 31, 2024 | 77.76M | 56.96% |
| Dec 29, 2023 | 49.54M | -84.17% |
| Dec 30, 2022 | 312.99M | -37.97% |
| Dec 31, 2021 | 504.59M | -6.70% |
| Aug 27, 2021 | 540.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Conexeu Sciences | 222.36M |
| Compugen | 222.27M |
| Protara Therapeutics | 220.32M |
| Coherus Oncology | 217.49M |
| AC Immune | 217.25M |
| Cellectis | 206.12M |
| Keros Therapeutics | 199.30M |
| Greenwich LifeSciences | 198.16M |